Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of risk prediction updates from commercial genome-wide scans.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Aug 2009

Mihaescu Raluca, van Hoek Mandy, Sijbrands Eric J G, Uitterlinden André G, Witteman Jacqueline C M, Hofman Albert, van Duijn Cornelia M, Janssens A Cecile J W

Abstract excerpt

PURPOSE: Commercial internet-based companies offer genome-wide scans to predict the risk of common diseases and personalize nutrition and lifestyle recommendations. These risk estimates are updated with every new gene discovery. METHODS: To assess the benefits of updating risk information in comm...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Mass Index
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Incidence

Share to Netherlands

Share to Prevalence

Share to TCF Transcription Factors

Share to Transcription Factor 7-Like 2 Protein

Source

Identifiers

PMID: 19636253
DOI: 10.1097/GIM.0b013e3181b13a4f

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19636253-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of risk prediction updates from commercial genome-wide scans.PMID 19636253Read ↗

Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review.Semantic proximity Read ↗

Recommendations from the EGAPP Working Group: does genomic profiling to assess type 2 diabetes risk improve health outcomes?Semantic proximity Read ↗

Real-World Utility of GWAS-Based Diabetes Mellitus Panel Testing.Semantic proximity Read ↗

Combining information from common type 2 diabetes risk polymorphisms improves disease prediction.Semantic proximity Read ↗

TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121,174 subjects.Semantic proximity Read ↗

TCF7L2 gene variants predispose to the development of type 2 diabetes mellitus among individuals with metabolic syndromeSemantic proximity Read ↗

Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults: the Cardiovascular Risk in Young Finns Study.Semantic proximity Read ↗

Polymorphism of the Transcription Factor 7-Like 2 Gene (TCF7L2) Interacts with Obesity on Type-2 Diabetes in the PREDIMED Study Emphasizing the Heterogeneity of Genetic Variants in Type-2 Diabetes Risk Prediction: Time for Obesity-Specific Genetic Risk Scores.Semantic proximity Read ↗

Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study.Semantic proximity Read ↗

Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes.Semantic proximity Read ↗

Reclassification of genetic-based risk predictions as GWAS data accumulate.Semantic proximity Read ↗

Effects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.